1 ml of solution contains
- Active ingredient – taurine 40.0 mg;
- Excipients: benzalkonium chloride, water for injection.
When applied topically, systemic absorption is low.
In the tissues of the body, it practically does not undergo oxidation. It is found in the free form in the liver, muscles, cardiac, nervous, brain tissues, in the blood (more in the blood cells than in the plasma). Excreted by the kidneys.
Taurine is a sulfur-containing amino acid formed in the body during the conversion of cysteine. Stimulates the processes of reparation and regeneration in dystrophic diseases and diseases accompanied by a significant metabolic disorder of the eye tissues.
It contributes to the normalization of the function of cell membranes, the activation of energy and metabolic processes, the preservation of the electrolyte composition of the cytoplasm due to the accumulation of K + and Ca2 +, and the improvement of the conditions for conducting a nerve impulse.
Indications for use
- Dystrophic lesions of the retina
- Dystrophy and trauma of the cornea
- Cataract (senile, diabetic, traumatic and radiation)
Dosage and administration
For cataracts, Taufon® is prescribed in the form of instillations, 2-3 drops in each eye 2-4 times a day, daily for 3 months. Courses are repeated at monthly intervals. For injuries, apply in the same doses for 1 month.
- Allergic reactions
- Increased individual sensitivity to the components of the drug
- Children’s age up to 18 years
There is evidence of the effectiveness of the drug when used together with β-blockers for the treatment of open-angle glaucoma.
Strengthening the effect is achieved by increasing the ease of outflow and reducing the production of aqueous humor.
If necessary, the simultaneous use of other ophthalmic drugs, the interval between the use of taurine and other drugs should be at least 10-15 minutes.
If the integrity of the vial is violated, as well as if the solution becomes cloudy, the drug should not be used.
When instilled does not cause burning.
The preservative benzalkonium chloride contained in the preparation can irritate the eyes when wearing contact lenses, so any contact lenses should be removed before instillation and worn no earlier than after
It is necessary to ensure that the tip of the dropper bottle does not come into contact with other objects and surfaces. After instillation, close the dropper bottle tightly with a cap.
Pregnancy and lactation
Sufficient experience in the use of the drug during pregnancy, breastfeeding is not. It is possible to use Taufon® as prescribed by the attending physician, if the expected therapeutic effect exceeds the risk of developing possible side effects for the fetus and child.
Application in pediatrics
Data on the efficacy and safety of the drug in children under 18 years of age are not available.
Features of the influence of the drug on the ability to drive a vehicle or potentially dangerous mechanisms
Does not affect the ability to drive a vehicle or potentially dangerous machinery.
There are no data on overdose.
Store at temperatures from 15 ° C to 25 ° C, protected from light.
Keep out of the reach of children!
Shelf life – 2.5 years
The shelf life of the drug after opening the vial is 4 weeks.
Do not use after the expiration date.